Clinical Trial Update: Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

View source ↗

Summary

This clinical trial registry entry describes a long-term follow-up study of a lentiviral-based gene-edited immune cell therapy for several B-cell lymphomas, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma Grade 3a
• Follicular Lymphoma Grade 3b
• Large B-cell Lymphoma
• Mediastinal Large B-cell Lymphoma

Snippet

Sponsor: Pell Bio-Med Technology Co., Ltd. | Conditions: Diffuse Large B Cell Lymphoma, Large B-cell Lymphoma | Status: RECRUITING